Janux Therapeutics Inc
JANXLatest QuantConomy context for JANX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Janux Therapeutics Inc
QuantConomy has a structured record for JANX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- JANX
- Name
- Janux Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- fmp alpaca alphavantage sec nasdaq
Recent signals for JANX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| other event | neutral | 70 | Jun 23, 08:10 PM | JANX filed 8-K: Other Events - 1 material event - [strong neutral signal] |
| earnings release | neutral | 40 | Feb 26, 12:00 AM | JANX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-26. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| ten percent owner | neutral | 37 | Jun 13, 12:40 AM | RA CAPITAL MANAGEMENT, L.P. (Director, 10% Owner) was granted JANX shares ($0.00M) - 5500 shares - [weak neutral signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| JANX | NASDAQ | fmp | Janux Therapeutics, Inc. |
| JANX | NASDAQ | alpaca | Janux Therapeutics, Inc. Common Stock |
| JANX | NASDAQ | alphavantage | Janux Therapeutics Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Campbell David Alan | President and CEO | exercise | 7,000 | $4.21 | $29,470 | 4 on EDGAR |
| Jun 11, 2026 | CAPPS VICKIE L | Director | grant | 5,500 | $0.00 | $0 | 4 on EDGAR |
| Jun 11, 2026 | Hernday Natasha | Director | grant | 5,500 | $0.00 | $0 | 4 on EDGAR |
| Jun 11, 2026 | DOBMEIER ERIC | Director | grant | 5,500 | $0.00 | $0 | 4 on EDGAR |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | grant | 5,500 | $0.00 | $0 | 4 on EDGAR |
| Jun 11, 2026 | Barrett Ronald W | Director | grant | 5,500 | $0.00 | $0 | 4 on EDGAR |
| Jun 11, 2026 | Kung Winston | Director | grant | 5,500 | $0.00 | $0 | 4 on EDGAR |
| Jun 2, 2026 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | sale | 4,059 | $14.03 | $56,944 | 4 on EDGAR |
| May 11, 2026 | Dobek Maria | Vice President, Accounting | sale | 2,038 | $14.17 | $28,878 | 4 on EDGAR |
| Feb 2, 2026 | Go William | Chief Medical Officer | grant | 44,000 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | grant | 36,000 | $0.00 | $0 | 4 on EDGAR |
| Jan 2, 2026 | Campbell David Alan | President and CEO | sale | 8,072 | $13.73 | $110,829 | 4 on EDGAR |
| Jan 2, 2026 | McIver Zachariah | Chief Medical Officer | sale | 2,714 | $13.73 | $37,263 | 4 on EDGAR |
| Jan 2, 2026 | Dobek Maria | Vice President, Accounting | sale | 1,462 | $13.73 | $20,073 | 4 on EDGAR |
| Jan 2, 2026 | Meyer Andrew Hollman | Chief Business Officer | sale | 1,879 | $13.73 | $25,799 | 4 on EDGAR |
| Jan 2, 2026 | Winter Charles M. | Chief Technical Officer | sale | 2,401 | $13.73 | $32,966 | 4 on EDGAR |
| Jan 2, 2026 | DiRaimondo Thomas | Chief Scientific Officer | sale | 2,505 | $13.73 | $34,394 | 4 on EDGAR |
| Dec 1, 2025 | Meyer Andrew Hollman | Chief Business Officer | exercise | 3,333 | $10.59 | $35,296 | 4 on EDGAR |
| Nov 14, 2025 | Meyer Andrew Hollman | Chief Business Officer | exercise | 3,333 | $10.59 | $35,296 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query JANX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access